Demy-Colton’s  conferences are dedicated to facilitating the growth of the life sciences industry. Demy-Colton is committed to helping biopharmaceutical companies bring innovative new therapies to patients in need of them as quickly and as efficiently as possible. Demy-Colton conferences are characterized as high-value, targeted meetings that address specific needs of participants including C-suite biotechnology executives, pharmaceutical executives, and senior professional industry advisors.

Demy-Colton’s meetings may feature a combination of plenary sessions, workshops, case studies, company presentations, and partnering meetings.

ConferenceLogos_CEOSummit_400

Napa

July 11-13, 2017

A private, think tank-style meeting that brings together biotech industry leaders who are united by the common goal of driving responsible growth and innovation while reaping the rewards of biotech’s new golden age. The fully interactive forum engages CEOs and other industry leaders in a dialogue that addresses the challenges of navigating the rapidly evolving biotech landscape while at the same time reshaping the industry.

 

Enniskerry, Co. Wicklow, Ireland

July 17-19, 2017

A private, think tank-style meeting that brings together biotech industry leaders who are united by the common goal of driving responsible growth and innovation while reaping the rewards of biotech’s new golden age. The fully interactive forum engages CEOs and other industry leaders in a dialogue that addresses the challenges of navigating the rapidly evolving biotech landscape while at the same time reshaping the industry.

 

ConferenceLogos_BTS_400

San Francisco

January 8-10, 2018

One of the largest annual investor and partnering conferences featuring 240+ small/mid-cap public and private companies. The meeting has grown to include over 2,000 attendees. The event features multiple tracks of presenting companies, plenary sessions, workshops, networking as well as the opportunity to schedule one-on-one meetings.

 

 
MedtechShowcase_logo DigitalShowcase_logo

San Francisco

January 9-10, 2018

The rise of personalized medicine is creating a convergence of traditional therapeutic biopharmaceutical products with innovative diagnostic and/or drug delivery technologies. At plenary sessions and workshops, speakers with deep experience in the device and diagnostic industry will discuss the latest technologies with an eye to how these innovations will help advance biopharmaceutical innovation.

San Francisco

January 9-10, 2018

Digital health technologies will play a key role in the evolution of how disease will be treated in the future. This one-day event during Biotech Showcase includes plenaries and workshops that dissects the sector and identifies the key players. Covering issues such as the financing, lifecycle and regulatory path for these companies, the event focuses on how the sector will interact with incumbent biopharma companies.

 

ConferenceLogos_LSS_400 ConferenceLogos_TPHSD_400

New York City

2018

An early stage investor and business development conference that highlights innovation. The objective of the event is to connect biotech and academic innovators with the capital and strategic partners they will need to move new discoveries into clinical development. The two-day program features corporate presentations by promising young companies with transformative science that targets unmet medical needs. It also features informative plenary sessions, business workshops, and KOL sessions.

Boston

2018

A C-level meeting for biopharmaceutical industry executives who want to accelerate, explore and develop collaborations and partnerships with their counterparts in the most important Trans-Pacific health care markets including Japan, China, South Korea and North America. This is a must-attend meeting for executives who have, or want to develop, a Trans-Pacific strategy.